Hensin Tsao, MD, PhD
"Physician scientists are often pulled in multiple directions especially if resident and postdoctoral fellow training is involved. However, one undercurrent that ties all aspects of my life together is teaching. Teaching trainees is an obvious exercise and expectation in academic centers. However, research comes from the same fundamental passion. For me, research is about teaching the world and the scientific community lessons that we learned through experimentation. The primary purpose of the research engine is to increase our domain knowledge AND to transmit that information through publications, lectures and other writings. Whether one has a Doctor of Philosophy, Doctor of Medicine or any other form of a doctorate, remember the word “doctor” is derived from the Latin, docco, which means “to teach.""
Hensin Tsao, MD, PhD is a board-certified dermatologist and Professor of Dermatology at Harvard Medical School. Presently, he is Director of the Melanoma and Pigmented Lesion Center, the Melanoma Genetics Program, and the Skin Cancer Genetics Laboratory in the Wellman Center for Photomedicine, all of which are at the Massachusetts General Hospital. Beyond patient care, he dedicates much of his time to melanoma research and the education of medical students, dermatology residents, and fellows.
Hensin Tsao, MD, PhD received his undergraduate degree from Brown University where he graduated magna cum laude and Phi Beta Kappa. Later, he graduated Alpha Omega Alpha from the Columbia University College of Physicians and Surgeons with a MD degree and received his PhD from Columbia University Graduate School of Arts of Sciences. Dr. Tsao completed one year of clinical training in internal medicine and three years of dermatology residency, including one-year Melanoma Fellowship in the Harvard-affiliated hospitals. He concluded his training with a postdoctoral fellowship in the Division of Oncology at Massachusetts General Hospital.
Dr. Tsao is a two-time MRA funded investigator
Without you, melanoma research can't happen. Learn more about clinical trials.
Please support MRA's mission to end death and suffering due to melanoma. 100% of your donation will go directly to funding innovative melanoma research, without any overhead, admin, or fundraising expenses.
